Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | N15SW1DIV8 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Activin receptor type-2B antagonist | PubMed |
Primary Target | |
---|---|
activin A receptor type 2B |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Myositis, Inclusion Body | 3 | D018979 | ClinicalTrials |
Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
Cachexia | 2 | D002100 | ClinicalTrials |
Sarcopenia | 2 | D055948 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
Muscular Atrophy | 2 | D009133 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1356922-05-8 |
ChEMBL | CHEMBL3137353 |
FDA SRS | N15SW1DIV8 |
Guide to Pharmacology | 8086 |